AURARIX Trademark

Trademark Overview


On Thursday, June 21, 2018, a trademark application was filed for AURARIX with the United States Patent and Trademark Office. The USPTO has given the AURARIX trademark a serial number of 88009376. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2020. This trademark is owned by Cambium Medical Technologies, LLC. The AURARIX trademark is filed in the Pharmaceutical Products category with the following description:

Blood platelets for medical use
aurarix

General Information


Serial Number88009376
Word MarkAURARIX
Filing DateThursday, June 21, 2018
Status700 - REGISTERED
Status DateTuesday, April 14, 2020
Registration Number6034437
Registration DateTuesday, April 14, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2018

Trademark Statements


Goods and ServicesBlood platelets for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 27, 2018
Primary Code005
First Use Anywhere DateTuesday, June 12, 2018
First Use In Commerce DateTuesday, June 12, 2018

Trademark Owner History


Party NameCambium Medical Technologies, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30319

Party NameCambium Medical Technologies, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30319

Party NameCambium Medical Technologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30319

Trademark Events


Event DateEvent Description
Tuesday, April 14, 2020REGISTERED-PRINCIPAL REGISTER
Friday, March 13, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 12, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 4, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 11, 2020USE AMENDMENT FILED
Wednesday, March 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 11, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, August 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2019EXTENSION 1 GRANTED
Monday, August 12, 2019EXTENSION 1 FILED
Monday, August 12, 2019TEAS EXTENSION RECEIVED
Tuesday, February 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 19, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, October 18, 2018ASSIGNED TO LIE
Thursday, October 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 18, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, October 18, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, October 11, 2018ASSIGNED TO EXAMINER
Wednesday, June 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords


aurarix medical platelets blood